BOTULINUM TOXIN FORMULATIONS FOR ORAL ADMINISTRATION

Application 673/KOLNP/2005 published 2006-06-30, filed 2005-04-19
Pharmaceutical compositions comprising a botulinum toxin and a carrier for oral administration to a patient the formulation itself exhibiting a gastric retention due to mucoadhesion, flotation, sedimentation, expansion, delayed gastric emptying initiated by a pharmacological agent. (FIG. - Nil)

Applicant

ALLERGAN INC
2525 DUPONT DRIVE T2-7H IRVINE CA 92612 USA

Inventor

DONOVAN STEPHEN

International Info

Classification: A61K 35/74,39/08,9/00
Publication Number: WO 04/043430 A3
Application Date: 2003-11-03

Priority Information

10/288,906 US 2003-11-05